以上研究不仅揭开了病原体的新伎俩，还为未来设计“新型抗病作物”提供了灵感！且看马拉加大学的Miguel A. Botella研究团队在Plant cell &Environment上，发表了题为“Hidden in plain sight: ...

In a promising new study, scientists have adapted an experimental cancer treatment to control celiac disease. The method ...

Targeting a newly discovered vulnerability in the signals that cyst nematodes use to infect plant roots could be a powerful ...

eFFECTOR Therapeutics, Inc. SOLANA BEACH, Calif. and REDWOOD CITY, Calif., June 24, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) today announced that the Company has ...

Circulating CD28-KLRG1+CD8+ T cells as prognostic indicators in advanced NSCLC chemoimmunotherapy. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include ...

Newly discovered weapons of bacterial self-defense take different approaches to achieving the same goal: preventing a virus from spreading through the bacterial population.

Artificial intelligence (XGBoost) in predicting outcomes among CAR-T therapy patients: The impact of malnutrition and comorbidities using the National Inpatient Sample (2020-2022). Engineering ...

Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg have identified a previously undocumented, organ-specific ...

The research, co-authored by MD/Ph.D. student Samantha "Sammy" Tse-Kang and Read Pukkila-Worley, MD, professor of medicine, uncovered a mechanism of effector-triggered immunity in animals ...

Explore eFFECTOR Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for EFTR. Why eFFECTOR Therapeutics (EFTR) Shares Are Down Over 70% EFFECTOR ...

It’s the end of an era—eFFECTOR Therapeutics’ era to be exact. The oncology biotech has laid off staff as it plans to wind down, according to a June 24 company release. This includes ...

Immune effector cell-associated neurotoxicity syndrome (ICANS) is a possible side effect of certain immunotherapies. This condition causes inflammation in the brain, leading to symptoms.